About Embio Limited
Data last updated: 11 January 2026
Embio Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Malladi Industries Private Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 20 January 1986, the company has been in operation for over 40 years.
Registered with ROC Mumbai under CIN U24110MH1986PLC038680.
Capital: an authorised share capital of ₹43.62 Cr and a paid-up capital of ₹4.7 Cr. Formerly known as Emmellen Biotech Pharmaceuticals Ltd. It is led by directors including Madhusudan Rao Garimella and Ajit Tekchand Vaswani.
Last AGM: 22 September 2025. Financial statements filed for year ended 31 March 2025. Office: 501 Sentinel 5Th Floor Hiranandani Gardens Powai, Mumbai, Maharashtra, India – 400076.
As per the financials filed for FY 2025, the company reported a revenue of ₹274.76 Cr, a growth of 49% compared to the previous year.
The company has a workforce of approximately 600 employees as per the latest available data. It operates as a subsidiary of Malladi Industries Private Limited.
The company is associated with 1 brand - Embio. As per MCA filings, the company has open charges of ₹66.03 Cr and satisfied charges of ₹109.3 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website embio.co.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address501 Sentinel 5Th Floor Hiranandani Gardens Powai, Mumbai, Maharashtra, India – 400076
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Embio Limited
Embio Limited has one previous CIN (Corporate Identification Number): L24110MH1986PLC038680. The current CIN is U24110MH1986PLC038680, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110MH1986PLC038680 | Current |
| L24110MH1986PLC038680 | Previous |
Associated Brands with Embio Limited
Embio Limited operates one associated brand: Embio. These brands represent Embio Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| APIs and chiral intermediates are manufactured by Embio under contract. | embio.co.in |
Competitors & Alternatives of Embio Limited
Brands and companies operating in the same space as Embio Limited include Laurus Labs, Symbiotec, Sterling Pharma Solutions and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
|
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
|
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
|
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
|
|
APIs are manufactured and custom synthesis services are provided. | Somerset, United States, United States | 2004 |
|
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
|
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
|
|
APIs and intermediates are researched and manufactured, specializing in heterocycles. | Beijing, China, China | 2007 |
Business Activity of Embio Limited
Embio Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Embio Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Embio Limited
Embio Limited is audited by SSPA & Associates for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SSPA & Associates | Locked | Locked | Locked |
Complete auditor history for Embio Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Embio Limited
Embio Limited is currently managed by 5 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhusudan Rao Garimella | Director | 07 Aug 2017 | 9 Years 0 Months | Current |
| Ajit Tekchand Vaswani | Director | 16 Oct 2001 | 24 Years 9 Months | Current |
| Devesh Malladi | Managing Director | 01 Oct 2007 | 18 Years 10 Months | Current |
|
Raghavachari Kasthuri Rangan
Also directs:
Aptia Group India Private Limited
|
Director | 20 Sep 2024 | 1 Years 10 Months | Current |
| Aadya Malladi | Additional Director | 26 Jun 2025 | 1 Years 1 Months | Current |
Financials of Embio Limited FY 2025 filings available
Embio Limited reported revenue of ₹274.76 Cr (up 49.00% YoY) for FY 2025.
Ten-year financial statements for Embio Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Embio Limited
Shareholding and ownership data for Embio Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Embio Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2022 | Axis Bank Limited | ₹25 Cr | Open |
| 10 Dec 2012 | Biotechnology Industry Research Assistance Council | ₹2 Cr | Open |
| 03 Dec 2002 | Axis Bank Limited | ₹25 Cr | Open |
| 28 Jun 1995 | State Bank of India | ₹14.03 Cr | Open |
| 28 May 2015 | Hdfc Bank Limited | ₹30 Lakh | Satisfied |
Total charge records: 33 View all charges
Employees and EPFO Compliance at Embio Limited
Embio Limited has a workforce of 600 employees as of Apr 05, 2024.
Employee and EPFO history for Embio Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Embio Limited
GST registrations and filing compliance for Embio Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Embio Limited
Credit ratings, litigation, and regulatory alerts for Embio Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Embio Limited
MSME payment history for Embio Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Embio Limited
Corporate group structure for Embio Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Embio Limited
MCA filings and documents for Embio Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Embio Limited
Frequently Asked Questions about Embio Limited
Embio Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 20 January 1986 (40+ years old) and is registered under CIN U24110MH1986PLC038680. The company has 600 employees.
Embio Limited reported revenue of ₹274.76 Cr for FY 2025 (up 49.00% YoY).
The current directors of Embio Limited are:
- Madhusudan Rao Garimella - Director
- Ajit Tekchand Vaswani - Director
- Devesh Malladi - Managing Director
- Raghavachari Kasthuri Rangan - Director
- Aadya Malladi - Additional Director
The primary industry of Embio Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Embio Limited can be reached at the registered office: 501 Sentinel 5Th Floor Hiranandani Gardens Powai, Mumbai, Maharashtra, India – 400076, or through the website embio.co.in.
The authorised capital is ₹43.62 Cr, and the paid-up capital is ₹4.7 Cr.